A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Janssen Korea, Ltd., Korea1,700 enrolled

Overview

This is an observational study to estimate the proportion of patients diagnosed with RA visiting a medical internist in a general hospital in Korea who are candidates for anti-TNF α therapy.

Study Type

OBSERVATIONAL

Enrollment

1,700

Conditions

Rheumatoid Arthritis

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with RA * Visiting a medical internist in a study site during the study period on out patient basis * Able to give written informed consent voluntarily Exclusion Criteria: None

Locations (1)

Unnamed facility

Seoul, South Korea

Outcomes

Primary Outcomes

Number of anti-TNF α agent candidates fulfilling the reimbursement guideline of Korea government in total out-patients with RA

Time frame: Baseline

Number of anti-TNF α agent candidates based on the clinical judgement in total out- patients with RA

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.